Literature DB >> 21294713

The C2 domain of Tollip, a Toll-like receptor signalling regulator, exhibits broad preference for phosphoinositides.

Gayatri Ankem1, Sharmistha Mitra, Furong Sun, Anna C Moreno, Boonta Chutvirasakul, Hugo F Azurmendi, Liwu Li, Daniel G S Capelluto.   

Abstract

TLRs (Toll-like receptors) provide a mechanism for host defence immune responses. Activated TLRs lead to the recruitment of adaptor proteins to their cytosolic tails, which in turn promote the activation of IRAKs (interleukin-1 receptor-associated kinases). IRAKs act upon their transcription factor targets to influence the expression of genes involved in the immune response. Tollip (Toll-interacting protein) modulates IRAK function in the TLR signalling pathway. Tollip is multimodular, with a conserved C2 domain of unknown function. We found that the Tollip C2 domain preferentially interacts with phosphoinositides, most notably with PtdIns3P (phosphatidylinositol 3-phosphate) and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate), in a Ca2+-independent manner. However, NMR analysis demonstrates that the Tollip C2 domain binds Ca2+, which may be required to target the membrane interface. NMR and lipid-protein overlay analyses suggest that PtdIns3P and PtdIns(4,5)P2 share interacting residues in the protein. Kinetic studies reveal that the C2 domain reversibly binds PtdIns3P and PtdIns(4,5)P2, with affinity values in the low micromolar range. Mutational analysis identifies key PtdIns3P- and PtdIns(4,5)P2-binding conserved basic residues in the protein. Our findings suggest that basic residues of the C2 domain mediate membrane targeting of Tollip by interaction with phosphoinositides, which contribute to the observed partition of the protein in different subcellular compartments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294713     DOI: 10.1042/BJ20102160

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis.

Authors:  Javeed A Shah; Jay C Vary; Tran T H Chau; Nguyen D Bang; Nguyen T B Yen; Jeremy J Farrar; Sarah J Dunstan; Thomas R Hawn
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Toll-interacting protein differentially modulates HIF1α and STAT5-mediated genes in fibroblasts.

Authors:  Elizabeth Kowalski; Shuo Geng; Allison Rathes; Ran Lu; Liwu Li
Journal:  J Biol Chem       Date:  2018-06-19       Impact factor: 5.157

3.  Ubiquitin interacts with the Tollip C2 and CUE domains and inhibits binding of Tollip to phosphoinositides.

Authors:  Sharmistha Mitra; C Alicia Traughber; Mary K Brannon; Stephanie Gomez; Daniel G S Capelluto
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

Review 4.  Cellular and molecular interactions of phosphoinositides and peripheral proteins.

Authors:  Robert V Stahelin; Jordan L Scott; Cary T Frick
Journal:  Chem Phys Lipids       Date:  2014-02-17       Impact factor: 3.329

5.  Comparative gene identification 58/α/β hydrolase domain 5 lacks lysophosphatidic acid acyltransferase activity.

Authors:  Derek McMahon; Anna Dinh; Daniel Kurz; Dharika Shah; Gil-Soo Han; George M Carman; Dawn L Brasaemle
Journal:  J Lipid Res       Date:  2014-05-30       Impact factor: 5.922

6.  Endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: alternations in Toll-like receptor 2 and 4 signaling pathway.

Authors:  Ying Sun; Hui Li; Meng-Jun Sun; Yang-Yu Zheng; Dan-Jun Gong; Yan Xu
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

7.  Endocytic Adaptor Protein Tollip Inhibits Canonical Wnt Signaling.

Authors:  Anna Toruń; Ewelina Szymańska; Irinka Castanon; Lidia Wolińska-Nizioł; Anna Bartosik; Kamil Jastrzębski; Magdalena Miętkowska; Marcos González-Gaitán; Marta Miaczynska
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 8.  Toll-Interacting Protein in Resolving and Non-Resolving Inflammation.

Authors:  Elizabeth J A Kowalski; Liwu Li
Journal:  Front Immunol       Date:  2017-05-05       Impact factor: 7.561

Review 9.  Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease.

Authors:  Xiaoyun Li; Gillian C Goobie; Yingze Zhang
Journal:  J Mol Med (Berl)       Date:  2020-10-31       Impact factor: 4.599

10.  An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport.

Authors:  Marlieke L M Jongsma; Ilana Berlin; Ruud H M Wijdeven; Lennert Janssen; George M C Janssen; Malgorzata A Garstka; Hans Janssen; Mark Mensink; Peter A van Veelen; Robbert M Spaapen; Jacques Neefjes
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.